ARCHIVES

Roferon A Application Marred By Mission Data, Protocol, Compliance

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014